default author photo

John DeCoteau

University of Saskatchewan - Department of Pathology and Laboratory Medicine

Saskatoon, Saskatchewan

Canada

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

DDX41 Is Required to Activate and Modulate cGAS-STING Activation

Number of pages: 109 Posted: 14 Jun 2021
University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Illinois at Chicago - Department of Microbiology and Immunology, Kumamoto University - Department of Molecular Laboratory Medicine, Saskatchewan Cancer Agency, University of Saskatchewan - Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), Saskatchewan Cancer Agency, University of Saskatchewan - Department of Veterinary Microbiology, Saskatchewan Cancer Agency, University of Saskatchewan - Department of Pathology and Laboratory Medicine, Saskatchewan Cancer Agency, Saskatchewan Cancer Agency, University of Saskatchewan - Department of Pathology and Laboratory Medicine, University of Saskatchewan - Department of Veterinary Microbiology, Kumamoto University - Department of Molecular Laboratory Medicine, University of Illinois at Chicago - Department of Microbiology and Immunology and University of Saskatchewan, College of Medicine, Department of Biochemistry, Microbiology, and Immunology
Downloads 46 (1,121,190)

Abstract:

Loading...

DDX41, cGAS, STING, unwinding, annealing, acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)